These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 11759057)
41. Review of renal oncocytoma with focus on clinical and pathobiological aspects. Kuroda N; Toi M; Hiroi M; Shuin T; Enzan H Histol Histopathol; 2003 Jul; 18(3):935-42. PubMed ID: 12792905 [TBL] [Abstract][Full Text] [Related]
42. Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study. Rocca PC; Brunelli M; Gobbo S; Eccher A; Bragantini E; Mina MM; Ficarra V; Zattoni F; Zamò A; Pea M; Scarpa A; Chilosi M; Menestrina F; Bonetti F; Eble JN; Martignoni G Mod Pathol; 2007 Jul; 20(7):722-8. PubMed ID: 17483815 [TBL] [Abstract][Full Text] [Related]
43. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma. Jain S; Roy S; Amin M; Acquafondata M; Yin M; Laframboise W; Bastacky S; Pantanowitz L; Dhir R; Parwani A Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843 [TBL] [Abstract][Full Text] [Related]
44. Parvalbumin is constantly expressed in chromophobe renal carcinoma. Martignoni G; Pea M; Chilosi M; Brunelli M; Scarpa A; Colato C; Tardanico R; Zamboni G; Bonetti F Mod Pathol; 2001 Aug; 14(8):760-7. PubMed ID: 11504835 [TBL] [Abstract][Full Text] [Related]
45. The diagnostic and prognostic utility of claudin expression in renal cell neoplasms. Lechpammer M; Resnick MB; Sabo E; Yakirevich E; Greaves WO; Sciandra KT; Tavares R; Noble LC; DeLellis RA; Wang LJ Mod Pathol; 2008 Nov; 21(11):1320-9. PubMed ID: 18587324 [TBL] [Abstract][Full Text] [Related]
46. Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms. Shen SS; Krishna B; Chirala R; Amato RJ; Truong LD Mod Pathol; 2005 Jul; 18(7):933-40. PubMed ID: 15696118 [TBL] [Abstract][Full Text] [Related]
47. Immunostaining characteristics of irisin in benign and malignant renal cancers. Kuloğlu T; Artaş G; Yardim M; Sahin I; Aydin Y; Beyoğlu N; Özercan IH; Yalcin MH; Ugur K; Aydin S Biotech Histochem; 2019 Aug; 94(6):435-441. PubMed ID: 30896263 [TBL] [Abstract][Full Text] [Related]
48. Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI. Akın IB; Altay C; Güler E; Çamlıdağ İ; Harman M; Danacı M; Tuna B; Yörükoğlu K; Seçil M Diagn Interv Radiol; 2019 Jan; 25(1):5-13. PubMed ID: 30644365 [TBL] [Abstract][Full Text] [Related]
49. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma. Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535 [TBL] [Abstract][Full Text] [Related]
50. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance]. Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232 [TBL] [Abstract][Full Text] [Related]
51. Primary collision tumors of the kidney composed of oncocytoma and papillary renal cell carcinoma: A review. McCroskey Z; Sim SJ; Selzman AA; Ayala AG; Ro JY Ann Diagn Pathol; 2017 Aug; 29():32-36. PubMed ID: 28807339 [TBL] [Abstract][Full Text] [Related]
52. Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. Patton KT; Tretiakova MS; Yao JL; Papavero V; Huo L; Adley BP; Wu G; Huang J; Pins MR; Teh BT; Yang XJ Am J Surg Pathol; 2004 Aug; 28(8):1045-50. PubMed ID: 15252311 [TBL] [Abstract][Full Text] [Related]
53. [Expression and clinical significance of kidney injury molecule-1 in renal epithelial neoplasms]. Dong YC; Wu B; Wang JD; Rao Q; Ma HH; Zhang RS; Zhou HB; Lu ZF; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):35-9. PubMed ID: 20388397 [TBL] [Abstract][Full Text] [Related]
54. Renal oncocytoma and chromophobe renal cell carcinoma. A comparison of colloidal iron staining and electron microscopy. Skinnider BF; Jones EC Am J Clin Pathol; 1999 Jun; 111(6):796-803. PubMed ID: 10361516 [TBL] [Abstract][Full Text] [Related]
55. Analysis of differentially expressed mitochondrial proteins in chromophobe renal cell carcinomas and renal oncocytomas by 2-D gel electrophoresis. Yusenko MV; Ruppert T; Kovacs G Int J Biol Sci; 2010 Apr; 6(3):213-24. PubMed ID: 20440404 [TBL] [Abstract][Full Text] [Related]
56. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study. Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004 [TBL] [Abstract][Full Text] [Related]
57. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma? Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253 [TBL] [Abstract][Full Text] [Related]
58. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors. Tickoo SK; Amin MB; Linden MD; Lee MW; Zarbo RJ Am J Surg Pathol; 1997 Aug; 21(8):922-30. PubMed ID: 9255255 [TBL] [Abstract][Full Text] [Related]
59. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT. Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547 [TBL] [Abstract][Full Text] [Related]
60. Alpha-methyl CoA racemase expression in renal cell carcinomas. Molinié V; Balaton A; Rotman S; Mansouri D; De Pinieux I; Homsi T; Guillou L Hum Pathol; 2006 Jun; 37(6):698-703. PubMed ID: 16733210 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]